NovoCure (NVCR) P/E (2015 - 2026)
NovoCure (NVCR) P/E from Oct 2, 2015 to Jun 3, 2026. The TTM NovoCure (NVCR) P/E is -6.42. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of NovoCure (NVCR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -6.42 | +9.70% |
| 2025 | -5.85 | -69.39% |
| 2024 | -19.11 | +70.38% |
| 2023 | -11.22 | -92.74% |
| 2022 | -154.52 | -47.45% |
| 2021 | -294.05 | -128.30% |
| 2020 | 1.04K | -455.20% |
| 2019 | -292.56 | +503.09% |
| 2018 | -48.51 | +98.60% |
| 2017 | -24.43 | +422.23% |
| 2016 | -4.68 | -70.51% |
| 2015 | -15.86 | N/A |
Comparison NovoCure (NVCR) P/E with competitors
NovoCure (NVCR) P/E is -6.42.